Mizuho Securities Downgrades Auxilium Pharmaceuticals To Neutral

Analysts at Mizuho Securities downgraded Auxilium Pharmaceuticals

from Buy to Neutral. The price target for Auxilium Pharmaceuticals has been lowered from $37.00 to $33.00. Auxilium Pharmaceuticals shares have climbed 87.41% over the past 52 weeks, while the S&P 500 index has gained 13.21% in the same period. Auxilium Pharma shares jumped 9.01% to close at $32.44 yesterday.